It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A clinical implementation of cell-based bone regeneration in combination with scaffold materials requires the development of efficient, controlled and reproducible seeding procedures and a tailor-made bioreactor design. A perfusion system for efficient, homogeneous, and rapid seeding with human adipogenic stem cells in bone substitute scaffolds was designed. Variants concerning medium inlet and outlet port geometry, i.e. cylindrical or conical diffuser, cell concentration, perfusion mode and perfusion rates were simulated in silico. Cell distribution during perfusion was monitored by dynamic [18F]FDG micro-PET/CT and validated by laser scanning microscopy with three-dimensional image reconstruction. By iterative feedback of the in silico and in vitro experiments, the homogeneity of cell distribution throughout the scaffold was optimized with adjustment of flow rates, cell density and perfusion properties. Finally, a bioreactor with a conical diffusor geometry was developed, that allows a homogeneous cell seeding (hoover coefficient: 0.24) in less than 60 min with an oscillating perfusion mode. During this short period of time, the cells initially adhere within the entire scaffold and stay viable. After two weeks, the formation of several cell layers was observed, which was associated with an osteogenic differentiation process. This newly designed bioreactor may be considered as a prototype for chairside application.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Rostock University Medical Center, Experimental Research Laboratory, Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, Rostock, Germany (GRID:grid.413108.f) (ISNI:0000 0000 9737 0454)
2 Institute for Implant Technology and Biomaterials e.V, Rostock, Germany (GRID:grid.413108.f)
3 Rostock University Medical Center, Core Facility Multimodal Small Animal Imaging, Rostock, Germany (GRID:grid.413108.f) (ISNI:0000 0000 9737 0454)
4 Rostock University Medical Center, Radiopharmacy, Department of Nuclear Medicine, Rostock, Germany (GRID:grid.413108.f) (ISNI:0000 0000 9737 0454)
5 Rostock University Medical Center, Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, Rostock, Germany (GRID:grid.413108.f) (ISNI:0000 0000 9737 0454)
6 Rostock University Medical Center, Department of Nuclear Medicine, Rostock, Germany (GRID:grid.413108.f) (ISNI:0000 0000 9737 0454)
7 Rostock University Medical Center, Experimental Research Laboratory, Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, Rostock, Germany (GRID:grid.413108.f) (ISNI:0000 0000 9737 0454); Rostock University Medical Center, Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, Rostock, Germany (GRID:grid.413108.f) (ISNI:0000 0000 9737 0454)